KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Short term Debt (2016 - 2025)

Pfizer (PFE) has disclosed Short term Debt for 17 consecutive years, with $4.3 billion as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt fell 55.63% to $4.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 billion, a 55.63% decrease, with the full-year FY2023 number at $10.4 billion, up 251.44% from a year prior.
  • Short term Debt was $4.3 billion for Q3 2025 at Pfizer, down from $4.5 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $10.4 billion in Q4 2023 to a low of $2.2 billion in Q4 2021.
  • A 5-year average of $5.3 billion and a median of $4.2 billion in 2023 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: soared 251.44% in 2023, then plummeted 55.63% in 2025.
  • Pfizer's Short term Debt stood at $2.2 billion in 2021, then surged by 31.41% to $2.9 billion in 2022, then skyrocketed by 251.44% to $10.4 billion in 2023, then fell by 6.29% to $9.7 billion in 2024, then crashed by 55.63% to $4.3 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Short term Debt are $4.3 billion (Q3 2025), $4.5 billion (Q1 2025), and $9.7 billion (Q3 2024).